Stay updated on Efficacy of Bempedoic Acid 180mg with PCSK9 Inhibitor: Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Bempedoic Acid 180mg with PCSK9 Inhibitor: Clinical Trial page.

Latest updates to the Efficacy of Bempedoic Acid 180mg with PCSK9 Inhibitor: Clinical Trial page
- Check7 days agoChange DetectedFooter revision stamp updated from v3.6.2 to v3.6.3, indicating a new build/version of the ClinicalTrials.gov page.SummaryDifference0.1%

- Check14 days agoChange DetectedThe revision tag on the page updates from v3.6.0 to v3.6.2. This represents a minor platform version bump and does not alter study data or how a researcher interacts with the page.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRecruitment information now states that the study is no longer looking for participants, signaling that enrollment is closed. The page revision has been updated to v3.6.0, and the prior revision label v3.5.5 has been removed from the history.SummaryDifference0.2%

- Check35 days agoChange DetectedThe site footer now shows Revision: v3.5.5 in place of the previous Revision: v3.5.4, indicating the current software version.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, signaling a small site update. No substantive study content or data appear to be altered.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page’s platform release/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site software revision rather than any change to the trial record content.SummaryDifference0.1%

Stay in the know with updates to Efficacy of Bempedoic Acid 180mg with PCSK9 Inhibitor: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Bempedoic Acid 180mg with PCSK9 Inhibitor: Clinical Trial page.